4
Malgor et al from the Mayo Clinic reported similar
recurrence rates at 2 years in patients treated with intraluminal stents in the SMA compared with those treated
with stents in both the SMA and CA. It is conceivable
that the lack of signiÔ¨Åcant difference in these studies
was due to the small sample size and a type 2 error.
Furthermore, there may have been a selection bias
with stent placement in both the SMA and CA reserved